Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)

Blossom Cm Stephan1, Fiona E Matthews, Kay-Tee Khaw

  • 1Department of Public Health and Primary Care, Institute of Public Health, The University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK. bcms2@cam.ac.uk.

Insights

Understanding vascular cognitive impairment, no dementia (VCIND) is crucial for predicting dementia risk. Research is exploring VCIND

Area of Science:

  • Neurology
  • Cognitive Science

Background:

  • Identifying dementia causes is vital for prevention and treatment.
  • Mild cognitive impairment (MCI) is a controversial prodromal dementia predictor.
  • Vascular cognitive impairment (VCI) describes cognitive changes from vascular causes.

Purpose of the Study:

  • To review the concept of vascular cognitive impairment, no dementia (VCIND).
  • To identify recent developments and controversies in VCIND nosology.
  • To explore VCIND's application in screening individuals at risk for dementia.

Main Methods:

  • Literature review of VCIND concept, diagnostics, and predictive value.
  • Analysis of existing research on neurodegenerative and vascular cognitive disorders.
  • Examination of diagnostic criteria for the VCI spectrum.

Main Results:

  • The mildest stage of VCI, VCIND, is poorly understood.
  • Distinguishing VCIND from MCI is challenging due to overlapping pathologies.
  • The predictive accuracy of VCIND for dementia progression requires further investigation.

Conclusions:

  • VCIND requires clearer diagnostic criteria to encompass the full VCI spectrum.
  • Further research is needed to determine if VCIND is distinct from MCI.
  • VCIND holds potential for screening individuals at risk of vascular dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...